1. Market Research
  2. > multiple sclerosis Industry
24/7 Customer Support

Talk to Sam

+1 718 473 0872

multiple sclerosis Industry Statistics

66 reports for Multiple Sclerosis

Purchase Reports From Reputable Market Research Publishers
(From $ 350 - $ 10 995)

Multiple Sclerosis Therapeutics Market Analysis By Drug Class (Immunomodulators, Immunosuppressant, Copaxone, Avonex, Gilenya, Tysabri, Betaseron, Tecfidera, Rebif, Ampyra, Aubagio, Extavia, Plegridy, Alemtuzumab, Glatopa, Siponimod, Ocrelizumab, Laquinim

Multiple Sclerosis Therapeutics Market Analysis By Drug Class Immunomodulators Immunosuppressant Copaxone Avonex Gilenya Tysabri Betaseron Tecfidera Rebif Ampyra Aubagio Extavia Plegridy Alemtuzumab Glatopa Siponimod Ocrelizumab Laquinim

  • $ 4 700
  • Industry report
  • May 2016
  • by Grand View Research

The global multiple sclerosis therapeutics market is expected to reach USD 24 8 billion by 2024 according to a new report by Grand View Research Inc The presence of high unmet clinical needs in developing


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.